DotBio
Biotechnology - Singapore, , Singapore
DotBio Details
DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore's Nanyang Technological University. For more information visit www.dotbiopharma.com
Website:
dotbiopharma.com
Employees:
1 - 10
HQ:
Location:
Singapore, , Singapore
Revenue:
DotBio Technologies
Email Providers
Gmail
Marketing Automation
Hubspot
Tag Management
Google Tag Manager
Fonts
Typekit
Other
Mobile Friendly